“Offering a new single-vial dose of CYANOKIT® is consistent with our company’s mission, as it will help streamline the administration process in a situation that requires an immediate response.”Ĭyanide (CN) can be released by virtually any material containing carbon and nitrogen when burned under high temperature and low oxygen conditions. “Meridian has a long history of supplying emergency care products to first responders and the medical community,” said Tom Handel, senior vice president of Commercial Pharmaceuticals for Meridian Medical Technologies, Inc. CYANOKIT 5 g is available for sale beginning this month. The new dose also features a 20 percent greater shelf life (36 months from the date of formulation). In addition to the full starting dose of CYANOKIT® 5 g now contained in a single vial, the new packaging is more compact than the previous presentation. The ability of first responders to recognize symptoms and treat victims of known or suspected cyanide poisoning quickly and efficiently-meaning, on the scene-could mean the difference between life and death,” said Rob Schnepp, chief of special operations with the Alameda County (Calif.) Fire Department. “Cyanide may be found within the smoke of some closed-space fires and is an important factor in some deaths caused by smoke inhalation.Cyanide poisoning is a life-threatening situation requiring immediate medical attention. Food and Drug Administration for the treatment of either known or suspected cyanide poisoning. In this new presentation of CYANOKIT®, the entire starting dose of 5 g hydroxocobalamin is now provided in a single vial, replacing the previous kit containing two, 2.5-g vials. launch of a new single-vial dose of CYANOKIT® (hydroxocobalamin for injection) 5 g. – Meridian Medical Technologies™, Inc., a Pfizer company (NYSE: PFE), today announced the U.S.

Cyanide treatment kit